Methylation profiling

Dataset Information

0

Dynamic epigenetic changes to VHL occurs with sunitinib in metastatic clear cell renal cancer

ABSTRACT: The role of epigenetic changes, relative to mutations, with targeted therapy

ORGANISM(S): Homo sapiens

PROVIDER: GSE67700 | GEO | 2016/03/17

SECONDARY ACCESSION(S): PRJNA280722

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer.
| S-EPMC5041900 | biostudies-literature
Unknown Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer.
| S-EPMC3494437 | biostudies-literature
Unknown Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers.
| S-EPMC2662874 | biostudies-other
Unknown Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modifications.
| S-EPMC4326587 | biostudies-literature
Unknown Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma.
| S-EPMC5580299 | biostudies-literature
Unknown The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer.
| S-EPMC2994212 | biostudies-other
Unknown Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear‑cell renal cell carcinoma treated with sunitinib as first‑line treatment.
| S-EPMC6615924 | biostudies-literature
Unknown Cytosine 5-hydroxymethylation regulates VHL gene expression in renal clear cell carcinoma.
| S-EPMC5609960 | biostudies-literature
Unknown Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial.
| S-EPMC4879109 | biostudies-literature
Unknown Targeting HIF2? translation with Tempol in VHL-deficient clear cell renal cell carcinoma.
| S-EPMC3717806 | biostudies-other